BRN Discussion Ongoing

[gex]

Few flogs popping up lately...

 

[davidfitz]

New GenX320 Sensor Wins CES 2024 Innovation Award

Prophesee has been named a CES® 2024 Innovation Awards Honoree for its GenX320 Event-based Metavision sensor, the industry’s smallest and most power-efficient event-based vision sensor.

www.prophesee.ai

Well done partner.

Tech.

Looks promising, always love what comes out of the CES.

 

[Vladsblood]

I don’t quite understand what there is to be gained by sharing this information on this forum FF? I am absolutely staggered you would put this down into words on a public forum..

Why would you basically spell out to the world that there’s a group of investors who get private privileges with the company to partake in meetings that are not made open to all shareholders?

For some, it brings into question the sudden price and volume movement of a week ago and makes questionable your motives of suddenly reappearing here. You would NOT want to have been buying on market under such circumstances.

However, fret not.
I can say with unquestionable fact. All the people that attended such meetings have no measurable advantage over other shareholders. It often works the other way because you feel connected and are more likely to fall for the A-type speak of ambitious executives, over the plain and simple facts that stare us in the face.. Not yet commercially successful!

What it highlights most of all his how unprofessional it makes management of the company come across and continued poor form in the way they conduct business with select shareholders..

As always, this is just my opinion..

I don’t get it??? why fly around the country when you have nothing new in information???? Then you won’t even give a timeline after 2-3 years

 

[Vladsblood]

My old mate ArneeT was a great Policeman and then a greater Barrister he’s been gone 21 years now…..But I always kept his advice….One pearler was…Manipulation comes and starts at the Top! Not from the bottom dwellers for they don’t control anything! Vlad

 

[David holland]

I don’t get it??? why fly around the country when you have nothing new in information???? Then you won’t even give a timeline after 2-3 years

I'm sure that question was asked at the AGM

 

[Xray1]

The chart will always tell all I need to know..
I think we still all want the same thing..

Just hope you’ve got yourself covered legally for disclosing in writing this sort of stuff FF..

All these private meetings recently held by the Co with select s/holders in attendance, imo shows and proves to me, that it is obviously not a case of a "Level Playing Field" situation and that all BRN s/holders are not considered as equals.

 

[Pom down under]

All these private meetings recently held by the Co with select s/holders in attendance, imo shows and proves to me, that it is obviously not a "Level Playing Field" situation and that all BRN s/holders are not considered as equals.

 

[DK6161]

I don’t quite understand what there is to be gained by sharing this information on this forum FF? I am absolutely staggered you would put this down into words on a public forum..

Why would you basically spell out to the world that there’s a group of investors who get private privileges with the company to partake in meetings that are not made open to all shareholders?

For some, it brings into question the sudden price and volume movement of a week ago and makes questionable your motives of suddenly reappearing here. You would NOT want to have been buying on market under such circumstances.

However, fret not.
I can say with unquestionable fact. All the people that attended such meetings have no measurable advantage over other shareholders. It often works the other way because you feel connected and are more likely to fall for the A-type speak of ambitious executives, over the plain and simple facts that stare us in the face.. Not yet commercially successful!

What it highlights most of all his how unprofessional it makes management of the company come across and continued poor form in the way they conduct business with select shareholders..

As always, this is just my opinion..

So that massive jump was purely driven by a secret meeting with select few shareholders?
I don't know whether to be happy with the update FF has given us, or to be very annoyed that only select few people were invited to get an update - as opposed to realeasing via email to all shareholders

 

[Shadow59]

Looking at the charts and the way it's trading, seems like an accumulation stage is happening. It will be interesting to see how fortunes have changed in the top 20 shareholders in the next 4C. Just my opinion.

 

[Vladsblood]

All these private meetings recently held by the Co with select s/holders in attendance, imo shows and proves to me, that it is obviously not a case of a "Level Playing Field" situation and that all BRN s/holders are not considered as equals.

With you X-ray on that mate…like the bidens “no drugs/guns/cashiers to see here… laugh my arse off!!
Boards get the flick OR bonuses only because of the Boards actions!! No one else is driving the company bus !! Their actions! Vlad

 

[SERA2g]

FYI: On the conference website, the session to which Pia Turcinov had been invited as a speaker, is missing the first and last panellist from your screenshot and also lists a different moderator. Unfortunately there was nothing else to find out, even when clicking that unmistakeable red Find Out More button.

Pia Turcinov AM - Indo-Pacific Space & Earth Conference

spaceandearthconference.com

View attachment 49630

Despite ending up in that cul-de-sac, I was still in dot-joining mood, so I had a closer look at Fund WA instead, where Pia Turcinov is a General Partner. They describe themselves as a “Seed To Series-A venture fund in Western Australia” and their mission statement is “to back the state’s innovative, high growth and scalable opportunities at the early commercialisation stages.”

View attachment 49632

View attachment 49635

So far, Fund WA has invested in two local start-ups (in August 2023 resp Sept 2023). The second one, medtech and biosensor company VitalTrace (www.vitaltrace.com.au), looks as if it was right up our alley, even though there is no specific mention of neuromorphic technology.

The people behind this innovative start-up based in Perth are hoping to commercialise their continuous scalp lactate monitoring DelivAssure biosensor, a real-time fetal distress monitoring device to detect hypoxia (lack of oxygen) in babies during labour, which they claim is superior to cardiotocography (CTG), the current gold standard of intrapartum (during childbirth) fetal monitoring. According to VitalTrace, DelivAssure will help clinicians to easily identify fetal distress during labour, allowing them to take early action to prevent complications such as brain damage, and at the same time reduce unnecessary C-sections.

Perth cardiologist A/Prof Dr Michael Nguyen, another General Partner of Fund WA, recently posted a short clip (worth watching) of VitalTrace being featured on Seven Network.

Thank you Seven network for promoting such a great company and the efforts of its founders. | Michael Nguyen

Thank you Seven network for promoting such a great company and the efforts of its founders. Thanks FundWA for supporting this innovation ecosystem.

www.linkedin.com

View attachment 49646

I subsequently searched for ‘VitalTrace’ here on TSE, which yielded one result: @Fact Finder had already come across this Perth start-up about 1.5 years ago.

View attachment 49668

Even if VitalTrace did not yet know about Akida back then, they would have found out about Brainchip’s disruptive tech by now through Pia Turcinov. Whether they are actually implementing it or not remains to be seen.

There is of course also the possibility that Fund WA invested in VitalTrace for the very reason the team behind the start-up plans on implementing Akida into their DelivAssure biosensor, on their mission “to create a new global standard of care for keeping mothers and babies safe during childbirth” and that Pia Turcinov and her investment partners are convinced that the resulting tech is going to be a winning combination, enabling the start-up founders’ vision for the novel biosensor to become an indispensable device for obstetricians and midwives around the globe, saving lives and helping to prevent birth complications due to hypoxia and avoiding unnecessary emergency C-sections. And all of this resulting in a massive decrease in healthcare costs, too.

While Brainchip is not (or not yet? another company behind an NDA?) listed as one of VitalTrace’s partners, I noticed both the University of Western Australia as well as the Perron Institute for Neurological and Translational Science in Perth are, and we have connections to both institutions through the three members on our Scientific Advisory Board: Prof Adam Osseiran, Professor Barry Marshall as well as Prof Alan Harvey. Of course there are also countless other potential (non BRN-related) connections between VitalTrace and the Perron Institute resp UWA. Unfortunately, I couldn’t spot any of our SAB member names on the university project pages I found (eg https://research-repository.uwa.edu...el-monitoring-device-to-detect-hypoxia-during and more links to collaborations with UTS and Monash over a three year period from 01/01/2022-31/12/2024), but they could still have put VitalTrace in touch with Brainchip or vice versa.

And even if Brainchip is not involved, I sincerely hope this innovative Perth start-up will be successful in commercialising their invention.

FundWA announces 2nd investment, in VitalTrace​

By
Pankaj Sharma
-
21 September 2023
0
422
https://www.facebook.com/sharer.php?u=https://startupnews.com.au/2023/09/21/fundwa-announces-2nd-investment-in-vitaltrace/
https://twitter.com/intent/tweet?text=FundWA+announces+2nd+investment,+in+VitalTrace&url=https://startupnews.com.au/2023/09/21/fundwa-announces-2nd-investment-in-vitaltrace/&via=Startup+News
https://www.linkedin.com/shareArticle?mini=true&url=https://startupnews.com.au/2023/09/21/fundwa-announces-2nd-investment-in-vitaltrace/&title=FundWA+announces+2nd+investment,+in+VitalTrace

FUND WA (Left to Right Fund WA's Glenn Butcher, Pia Turcinov, Dr Michael Nguyen, Trent Rachow. Absent are Asheesh Malaney General Partner and Glenn Murray Venture Partner. Photo supplied.

WA-based venture fund Fund WA has announced its second investment from its first fund in backing Perth-based medtech and biosensor company VitalTrace.
The former WA Innovator of the Year winners (2021, Wesfamers Wellbeing Award) co-founders Dr Arjun Kaushik and Dr Michael Challenor are leading cutting-edge research and developing manufacturing capability, all focused on solving a serious problem that is worth $3b per annum.

A recent event hosted by VitalTrace to celebrate the investment was an opportunity for FundWA investors to meet some of the team and hear about the most recent milestones reached in commercialising their world-first DelivAssurebiosensor.

VitalTrace team. Image supplied.



Glenn Butcher, CEO and one of the four General Partners of Fund WA said he was happy to support an investment to create a new global standard of care for keeping mothers and babies safe during childbirth.
“This is a WA startup, based here, manufacturing from here and taking this ground-breaking technology to the world, from WA,” he said.

“Our investment in VitalTrace is a commitment to supporting transformative West Australian innovation that can enhance the lives of countless individuals. Our focus is on high growth potential and is not limited to any specific industry sectors. We firmly believe investable talent can come from anywhere.”

VitalTrace product suite – including the DelivAssure biosensor (on the table). Image supplied

Earlier this year FundWA received support through the WA State Government’s New Industries Fund, from the Department of Jobs, Tourism, Science and Innovation which has provided some operational funding for the first three years to assist in the establishment of the fund under the WA Ventures Support (WAVES) pilot program.

To date, FundWA has vetted over 160 startup companies in WA and is actively encouraging early conversations with founders looking to scale through venture capital funding.
~~
For further information visit www.fundwa.com.au


View attachment 49666

Hi @Frangipani

I am well versed with both Fund WA and VitalTrace.

VitalTrace was a client of my accounting firm from circa 2018 to 2022. I personally prepared their tax compliance for the 2020 and 2021 financial years. I won't comment on Fund WA.

A few supplier searches may or may not have taken place within VitalTraces accounting system over those few years and word is it always came up unlucky

Their founders are Michael Challenor (CTO) and Arjun Kaushik (CEO). They met at a hackathon or incubator event from memory. Arjun is a medical doctor and Michael is a (from memory) chemical engineer and has a PhD in nanotechnology and robotics. Whilst a seemingly random duo, it worked out well for them with Arjun understanding the medical need for innovation in the obstetrics area of medicine and Michael being able to roll up the sleeves and work on a proof of concept to get things started.

They ended up raising a fair wack of money and have a very good presence in the WA MedTech scene.

I got along with Michael Challenor quite well. After they moved on to another accounting firm we caught up for a coffee and I was little more direct in asking about Brainchip. Michael hadn't heard of them, I explained the technology and told them it aligns extremely well with what they are trying to develop. He agreed and said he would look into it but also noted their main goal for now is to simply get their first device to market. They already had their funding locked away and plans in place for the development cycle, pivoting was out of the question given how far into development they were. This conversation was back in early 2022 so I didn't know it at the time but this attitude and existing capital commitment problem is an issue brainchip is currently dealing with. In other words, Brainchip's technology sounds great and is something they could consider for their next product, but they need to finish what they've started first.

I did offer to make an introduction to Brainchip for Michael and I think I might have sent an email to Adam Osseiran introducing the two to each other but I'm a little hazy on whether that was something I said I'd do but not sure if I actually did.

I've been watching their story closely because I feel invested given I worked with them for years, to my knowledge, their first product still hasn't been commercialised so I'm of the opinion akida isn't involved yet. You are correct though, the harmony is there and akida definitely has a place in their technology.

I think the development of their sensor is taking longer than they had planned. By coincidence, my Fiances step brother works for a company in Sydney that designs chips. We realised in discussion that we both had a link to their company through our work. He wasn't on the team working on VitalTrace's product design but did say the guys he works with has said what they were trying to build was not going to be easy.

Another Perth based Med Tech that has an eerily similar story to VitalTrace is a company called VeinTech. They are developing a product called the VeinWave which helps to find veins and therefore reduce failed canulation rates which are woeful and cost the hospital system hundreds of millions annually in consumable and nurses/doctors time and therefore wages etc. I know Nick Buckley (CEO) from VeinTech through my professional network, having arranged for him to speak to a tech group I was involved with a couple of years ago. The VeinWave could also benefit from some akida magic, and similarly, is likely to be more of a "maybe next time".

I might reach out to Nick and Michael and see if they are keen for a catch up soon.

Cheers

 

[Schnitzel lover]

All these private meetings recently held by the Co with select s/holders in attendance, imo shows and proves to me, that it is obviously not a case of a "Level Playing Field" situation and that all BRN s/holders are not considered as equals.

We all still want the same thing though. Successful BRN.. There’s a saying, “if it’s not in writing it never happened”

 

[Pom down under]

So that massive jump was purely driven by a secret meeting with select few shareholders?
I don't know whether to be happy with the update FF has given us, or to be very annoyed that only select few people were invited to get an update - as opposed to realeasing via email to all shareholders

Private meeting was bullshit and doesn’t sit well with me at all and was there a secret handshake to greet everyone. I was brought up everyone should be treated equally

 

[Xray1]

So that massive jump was purely driven by a secret meeting with select few shareholders?
I don't know whether to be happy with the update FF has given us, or to be very annoyed that only select few people were invited to get an update - as opposed to realeasing via email to all shareholders

This situation raises another concern imo as it specifically relates to the 8th Nov 2023 ASX SHARE PRICE QUERY and the 9th Nov 2023 "RESPONSE TO ASX QUERY" by the Co:

"8 November 2023 Reference: 84269 Ms Kim Clark Head of Corporate Services, Queensland Boardroom Pty Limited Suite 2227, Level 22, 127 Creek Street Brisbane QLD 4000 By email only. Dear Ms Clark Brainchip Holdings Ltd (‘BRN’): Price - Query ASX refers to the following: A. The change in the price of BRN’s securities from a low of $0.165 to $0.23 since close of trade 5 trading days ago. B. The change in the price of BRN’s securities from $0.18 to $0.23 since the start of the day. C. The significant increase in the volume of BRN’s securities traded since the start of the day. Request for information In light of this, ASX asks BRN to respond separately to each of the following questions and requests for information: 1. Is BRN aware of any information concerning it that has not been announced to the market which, if known by some in the market, could explain the recent trading in its securities?"

So that massive jump was purely driven by a secret meeting with select few shareholders?
I don't know whether to be happy with the update FF has given us, or to be very annoyed that only select few people were invited to get an update - as opposed to realeasing via email to all shareholders

FYI .......... It is concerning to me, that on the 9th Nov 2023 the company sent a "Response to ASX Query" stating:

Brainchip Holdings Limited (‘BRN’): Price - Query Brainchip Holdings Limited (BRN or Company) refers to your letter of 08 November 2023 and provides the following responses: 1. Is BRN aware of any information concerning it that has not been announced to the market which, if known by some in the market, could explain the recent trading in its securities? No

IMO .... Maybe the Co in its response back to the ASX on the 9th Nov 2023 should have raised and disclosed the issue of the Company having had held meetings with various selected ( by invitation only ) s/holders at those meetings rather than a meeting for all shareholders.

 

[wilzy123]

FWOAR.... the company must be doing something right today, we're up 2.5%!!

 

[The Pope]

What I find most interesting is how transparent you and the other manipulators are but I should not be surprised given the proven depths of human depravity.

Personal attacks, threats of spills, pompous claims of self importance and financial sophistication.

Uninformed claims that a spill will remove a CEO.

The ignorance and misinformation rains down like a river.

Go and read the Rules a spill has no implications for the Chairman or the CEO particularly when the spill is led by disgruntled retail shareholders who manage to cobble together 25% on two occasions. The existing Board simply nominates again and are elected because they don’t even have to get 50% of the possible vote at the spill meeting.

The only one’s who win from a spill are the shorts, the manipulators and the trolls.

Retail shareholders will always loose.

Sharing publicly available information has not and will not ever be a cause for concern however ignorance and sinister intent will always be a trigger to be careful as the purveyor is someone not to be trusted.

Those who might be influenced by these flawed individuals should ask why has not one of these individuals challenged or unpicked the information that is contained in my earlier post?

Why have they not identified the untruths?

Why have they not identified and laid bare the price sensitive insider information that they seek to rage against?

Can they not find it?

Why have they not considered that the CEO and Board of a publicly listed company randomly sampling the views of a group of shareholders to understand their concerns beyond the simplicity of the day to day share price might be a good thing?

It was clear that the shareholders who attended in Sydney cut across age, social circumstance and were not selected based on the size of their wallet or shareholding.

Or dare I say what institution they worked at or what broker they break bread with on the weekend.

They gave all the outward appearance of a random selection and not an elite group of so called sophisticated or institutional investors.

Does this failure to only speak with the so called elites offend their collective sense of entitlement?

Do they fear their position as controllers of wealth and hence power may be undermined?

Real people with real concerns such as wives, husbands, children, retirement plans, fixed incomes, mortgages, relatives and friends who had invested on their advice in other words real people who only had one thing in common they have invested their hard earned in Brainchip and had concerns like the genuine shareholders who post here.

While the attacks have been directed at me these warriors of all that is disgusting about the ASX and social media are at the same time denigrating all the other real shareholders who took up this first in their lifetime opportunity to have a voice and be heard by those in charge of the company they have invested in.

Who among this group here would if offered the same opportunity to be heard not accept with a virtuous heart?

It is clear what the individuals who have played the man instead of the ball are about and it is not ensuring that an investment in Brainchip pays off for all shareholders.

My opinion only DYOR though Blind Freddie says their intent is obvious.

Regards
Fact Finder

Hi FF

It’s much appreciated that you have shared information discussed from your recall on this apparently informal meeting that you and a select few retail investors were invited to attend with Sean and Co in Sydney on 6/11/23

The only things I would like to put on record in this forum on this apparent informal meeting is I would have loved to have had the opportunity to attend this meeting to meet and ask questions to Sean and listen carefully to how Sean etc responded. Im sure not the only one.
I also trust that the select few who attended have disclosed all key information discussed at the informal meeting (no advantage over other retail investors) and has been been shared to all on this forum (not limited to) and it isn't just selective recall only from attendees. I suggest this may work towards calming the tension with others from recent posts. Im sure you understand where I am coming from amd don’t take it to heart.

Also my recall from previous posts yesterday on this informal meeting is it did last 2hrs approx so I consider that is a solid timeframe to discuss and raise questions with Sean and co.
I would also suggest this timeframe was considerably longer than share holders had at the recent AGM in Sydney as a large group of retail shareholders. My recall is the BRN board members ran out of time and took a number of questions on notice and would get back to them. I’m unsure if that ever happened but happy to be corrected by Tony Dawe as he apparently reads posts in this forum.

Hope all have a good weekend whenever it starts. Mine started this morning. lol

Cheers
The Pope

 

[wilzy123]

Once again Wilzy. No substance added. At least we didn’t get a gif.

He actually makes a good point. Definitely not confused at all.

I think the disclosure of the special invite meeting and the secrecy of it all smells a little. It’s a bit like Sean and Tony have made the special meetings with the movers and shakers of TSEx to help calm the pitch fork wielding tribe. Might have back fired due to the tribe feeling a little betrayed and left of centre right at this point.

I hold what I believe to be a considerable sum of shares and belong to a group of friends, family and associates who together hold a very large number of shares. Our collective sentiment is definitely “concerned” with the current state of commercialisation but not “worried”. The need to brief a small number of individuals on this commercialisation strategy adds to the “ concern”. Schnitty has a right to also express an opinion as do I. Your right of reply doesn’t necessarily mean you are “right”.

I’m guessing your reply also reflects your “concern” on the current state of play.

Just sounds like people are feeling left out.

Yup

 

[Vladsblood]

This situation raises another concern imo as it specifically relates to the 8th Nov 2023 ASX SHARE PRICE QUERY and the 9th Nov 2023 "RESPONSE TO ASX QUERY" by the Co:

"8 November 2023 Reference: 84269 Ms Kim Clark Head of Corporate Services, Queensland Boardroom Pty Limited Suite 2227, Level 22, 127 Creek Street Brisbane QLD 4000 By email only. Dear Ms Clark Brainchip Holdings Ltd (‘BRN’): Price - Query ASX refers to the following: A. The change in the price of BRN’s securities from a low of $0.165 to $0.23 since close of trade 5 trading days ago. B. The change in the price of BRN’s securities from $0.18 to $0.23 since the start of the day. C. The significant increase in the volume of BRN’s securities traded since the start of the day. Request for information In light of this, ASX asks BRN to respond separately to each of the following questions and requests for information: 1. Is BRN aware of any information concerning it that has not been announced to the market which, if known by some in the market, could explain the recent trading in its securities?"


FYI .......... It is concerning to me, that on the 9th Nov 2023 the company sent a "Response to ASX Query" stating:

Brainchip Holdings Limited (‘BRN’): Price - Query Brainchip Holdings Limited (BRN or Company) refers to your letter of 08 November 2023 and provides the following responses: 1. Is BRN aware of any information concerning it that has not been announced to the market which, if known by some in the market, could explain the recent trading in its securities? No

IMO .... Maybe the Co in its response back to the ASX on the 9th Nov 2023 should have raised and disclosed the issue of the Company having had held meetings with various selected s/holders at those meetings rather than a meeting for all shareholders.

Well we should take the same stance as our management regarding our severely depleted SP…We aren’t going to discuss the SP and the SP will do what it’s gonna do…and now you our groupie mates keep the herd of mushrooms in the dark and tell them to stop manipulating!!
Their idiots so they’ll understand.
Well my turn at the agm will be related also to loss of value….no board spill for me but no wages for management UNTIL profits are showing. After all,us mushrooms don’t get paid until company is good and profitable…??do we???
Then let’s see how management feel in our boat . Vlad

 

[Rskiff]

So that massive jump was purely driven by a secret meeting with select few shareholders?
I don't know whether to be happy with the update FF has given us, or to be very annoyed that only select few people were invited to get an update - as opposed to realeasing via email to all shareholders

We did get a update via and . Some choose to have short memories. I'm not worried not getting an invite as nothing new disclosed but an attempt by the company to reach and continue to communicate to shareholders. Damned if they do and damned if they don't.

 

[M_C]

What a prestigious recognition from the tech world! 😃 We are so proud to be a CES 2024 Innovation Award Honoree for our Valeo SCALA 3 LiDAR in the "Vehicle Tech & Advanced Mobility" category… | Valeo

What a prestigious recognition from the tech world! 😃 We are so proud to be a CES 2024 Innovation Award Honoree for our Valeo SCALA 3 LiDAR in the "Vehicle Tech & Advanced Mobility" category. 🏆💚 With its high density point cloud and associated AI-based perception software, Valeo SCALA 3...

www.linkedin.com